A.D.A.M. (NASDAQ:ADAM) will release the third quarter earnings for 2009 on Thursday, November 12. The company will hold a conference call at 10:00 am ET that morning to discuss the financial results. Interested parties may hear the call by dialing 866.900.2647 or 706.758.3362 for international callers. Callers are encouraged to dial in ten minutes prior to the scheduled start of the call. The pass code will be 38400536.
Best Damn Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Stock Newsletter.
Those who are unable to participate may hear a replay of the presentation. The replay will be available from 2:00 pm ET November 12 to 11:59 pm ET November 1. To hear the replay, dial 800.642.1687 or 706.645.9291 for international callers. The pass code will be the same. A webcast of the conference will also be available for ninety days on the company’s website, www.adam.com.
A.D.A.M., Inc. provides online information and technology solutions for employers, benefits brokers, healthcare organizations and online media companies. The Company’s solutions includes health information and health decision support tools, which it markets to healthcare organizations, online media companies, and Internet search and technology firms; and benefits communications and decision support, human resources productivity, and benefits broker tools, which it markets to local and regional benefits brokers and national agencies with employer clients having less than 500 employees, and employers with more than 500 employees.
Sign up for the free Best Damn Penny Stocks newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
About Best Damn Penny Stocks
Best Damn Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
